By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic Genomics has raised $35 million in private equity financing through an ongoing funding round expected to reach $50 million, according to a filing with the US Securities and Exchange Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.